Rudolph: Nasal Microbiota With Red and Sore Nose

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-20

Study Completion Date

2017-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study will utilize the experimental rhinovirus infection model to study changes in skin microbiota in relation to skin erythema and soreness.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Experimental Human Rhinovirus Infection

NCT01823640

Common Cold

COMPLETED PHASE1

A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients

NCT03037957

Pharyngitis Bacterial

COMPLETED

A Study of Human Rhinovirus Type 16 (HRV-16) Following Administration in the Nose of Healthy Adult Volunteers

NCT01466738

Healthy

COMPLETED PHASE1

Hypertonic Saline Nasal Irrigation and Gargling for the Common Cold.

NCT02438579

Common Cold Upper Respiratory Tract Infections

COMPLETED NA

The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study

NCT07342582

Rhinovirus

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rhinovirus Challenge

Challenge with HRV-16

Group Type OTHER

Rhinovirus Challenge

Intervention Type OTHER

Challenge with HRV-16 virus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rhinovirus Challenge

Challenge with HRV-16 virus

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* self reported proneness to developing symptoms of nose redness and/or soreness
* sero-negative to HRV-16 at screening

Exclusion Criteria

* confirmed or self-reported allergic rhinitis
* history of nasal or otologic surgery
* use of anti-inflammatory medication, recent antibiotics or anti-histamines

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes